| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.1M | +199.0% |
| Cost of Revenue | $16.9M | +6068.4% |
| Gross Profit | -$15.8M | — |
| R&D Expense | $74.9M | -3.2% |
| SG&A Expense | $181.9M | -15.7% |
| Operating Income | -$391.8M | -3.7% |
| Interest Expense | $1.6M | -61.9% |
| Pre-tax Income | -$509.7M | +49.9% |
| Income Tax | -$3.9M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.3M | -93.4% |
| Accounts Receivable | $124K | -81.5% |
| Inventory | $37.5M | +123.1% |
| Current Assets | $63.2M | -68.1% |
| Total Assets | $178.6M | -57.6% |
| Current Liabilities | $183.2M | +31.2% |
| Long-term Debt | $5.4M | -94.5% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$185.6M | -3.6% |
| Capital Expenditures | $14.7M | +1.7% |
| Investing Cash Flow | -$16.1M | +85.0% |
| Financing Cash Flow | $56.8M | -84.2% |
| Free Cash Flow | -$200.3M | -3.4% |
| +64.6% |
| Net Income | -$457.1M | +53.0% |
| EPS (Basic) | -$1425.61 | +9.4% |
| Total Liabilities |
| $195.2M |
| +31.1% |
| Stockholders' Equity | -$28.6M | -113.7% |